NADOFARAGENE FIRADENOVEC-VNCG

NADOFARAGENE FIRADENOVEC-VNCG was reported 523 times

These side effects are most commonly reported by patients taking NADOFARAGENE FIRADENOVEC-VNCG:

# Side effect Count
0 INSTILLATION SITE DISCHARGE 107
1 BLADDER SPASM 62
2 DISEASE RECURRENCE 48
3 PYREXIA 40
4 FATIGUE 35
5 MICTURITION URGENCY 29
6 CHILLS 26
7 DRUG INEFFECTIVE 26
8 DEATH 25
9 EXPULSION OF MEDICATION 25
10 INFLUENZA LIKE ILLNESS 22
11 DYSURIA 21
12 HAEMATURIA 19
13 PAIN 19
14 DISEASE PROGRESSION 15
15 HEADACHE 15
16 INCORRECT PRODUCT ADMINISTRATION DURATION 14
17 POLLAKIURIA 14
18 BLADDER CANCER RECURRENT 13
19 NAUSEA 12
20 ASTHENIA 11
21 DIARRHOEA 11
22 INCORRECT DOSE ADMINISTERED 10
23 VOMITING 10
24 BLOOD URINE PRESENT 9
25 DECREASED APPETITE 9
26 INCONTINENCE 8
27 WEIGHT DECREASED 8
28 BLADDER NEOPLASM 7
29 DISCOMFORT 7
30 PRODUCT ADMINISTRATION INTERRUPTED 7
31 URINARY INCONTINENCE 7
32 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7
33 BLADDER DISCOMFORT 6
34 BURNING SENSATION 6
35 TREATMENT FAILURE 6
36 DIZZINESS 5
37 HOSPITALISATION 5
38 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5
39 MUSCLE SPASMS 5
40 NEOPLASM RECURRENCE 5
41 SEPSIS 5
42 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5
43 THERAPY NON-RESPONDER 5
44 CARDIAC DISORDER 4
45 CONFUSIONAL STATE 4
46 CYSTITIS 4
47 CYTOLOGY ABNORMAL 4
48 MALAISE 4
49 TREMOR 4
50 URINARY RETENTION 4
51 URINARY TRACT INFECTION 4
52 URINE OUTPUT DECREASED 4
53 ABDOMINAL PAIN LOWER 3
54 ARTHRALGIA 3
55 BLOOD CREATININE INCREASED 3
56 BRAIN FOG 3
57 CARCINOMA IN SITU 3
58 CYSTOSCOPY ABNORMAL 3
59 DISORIENTATION 3
60 DRUG INTOLERANCE 3
61 DYSPNOEA 3
62 FALL 3
63 INSTILLATION SITE IRRITATION 3
64 MENTAL STATUS CHANGES 3
65 MYALGIA 3
66 NEUROPATHY PERIPHERAL 3
67 PANCYTOPENIA 3
68 PRODUCT USE ISSUE 3
69 SLEEP DISORDER 3
70 SYNCOPE 3
71 URINARY CYSTECTOMY 3
72 ABDOMINAL DISTENSION 2
73 ACUTE KIDNEY INJURY 2
74 ADENOVIRUS INFECTION 2
75 ADVERSE DRUG REACTION 2
76 ADVERSE EVENT 2
77 AGEUSIA 2
78 ANAL INCONTINENCE 2
79 ATRIAL FIBRILLATION 2
80 BLADDER CANCER 2
81 BLADDER IRRITATION 2
82 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2
83 DEHYDRATION 2
84 DRY SKIN 2
85 ENCEPHALOPATHY 2
86 ERYTHEMA 2
87 EXPIRED PRODUCT ADMINISTERED 2
88 FEELING ABNORMAL 2
89 FEELING OF BODY TEMPERATURE CHANGE 2
90 FLANK PAIN 2
91 FLUSHING 2
92 GAIT DISTURBANCE 2
93 GAIT INABILITY 2
94 HEART RATE INCREASED 2
95 HOT FLUSH 2
96 HYPERHIDROSIS 2
97 HYPONATRAEMIA 2
98 ILLNESS 2
99 INFECTION 2
100 INSTILLATION SITE DISCOMFORT 2
101 LETHARGY 2
102 LOWER URINARY TRACT SYMPTOMS 2
103 MALIGNANT NEOPLASM PROGRESSION 2
104 OFF LABEL USE 2
105 PNEUMONIA 2
106 PRODUCT USE IN UNAPPROVED INDICATION 2
107 RADICAL CYSTECTOMY 2
108 RASH 2
109 RHINORRHOEA 2
110 TACHYCARDIA 2
111 UNRESPONSIVE TO STIMULI 2
112 URINARY TRACT DISCOMFORT 2
113 VULVOVAGINAL PRURITUS 2
114 WHITE BLOOD CELL COUNT INCREASED 2
115 ABDOMINAL DISCOMFORT 1
116 ABDOMINAL PAIN 1
117 ADVERSE REACTION 1
118 ALOPECIA 1
119 ANION GAP DECREASED 1
120 ANKLE FRACTURE 1
121 ANOSMIA 1
122 ARTHRITIS 1
123 BACK PAIN 1
124 BEDRIDDEN 1
125 BLADDER DISORDER 1
126 BLADDER OBSTRUCTION 1
127 BLADDER PAIN 1
128 BLADDER PAPILLOMA 1
129 BLADDER TRANSITIONAL CELL CARCINOMA 1
130 BLINDNESS UNILATERAL 1
131 BLOOD CALCIUM DECREASED 1
132 BLOOD CREATININE ABNORMAL 1
133 BLOOD GLUCOSE INCREASED 1
134 BLOOD POTASSIUM DECREASED 1
135 BLOOD PRESSURE INCREASED 1
136 BLOOD SODIUM DECREASED 1
137 BLOOD UREA INCREASED 1
138 BODY TEMPERATURE FLUCTUATION 1
139 BODY TEMPERATURE INCREASED 1
140 BONE CANCER 1
141 CALCULUS BLADDER 1
142 CARDIAC ARREST 1
143 CATHETER SITE HAEMORRHAGE 1
144 CHEST DISCOMFORT 1
145 CITROBACTER INFECTION 1
146 CLINICALLY ISOLATED SYNDROME 1
147 COLD FLASH 1
148 COMPUTERISED TOMOGRAM ABNORMAL 1
149 CONSTIPATION 1
150 CYSTITIS HAEMORRHAGIC 1
151 CYSTITIS NONINFECTIVE 1
152 CYTOKINE STORM 1
153 DEEP VEIN THROMBOSIS 1
154 DEMENTIA ALZHEIMER^S TYPE 1
155 DRY MOUTH 1
156 DYSARTHRIA 1
157 DYSGEUSIA 1
158 DYSKINESIA 1
159 DYSSTASIA 1
160 EAR DISCOMFORT 1
161 EXPOSURE VIA BODY FLUID 1
162 EXPOSURE VIA SKIN CONTACT 1
163 EXTRA DOSE ADMINISTERED 1
164 FACIAL PAIN 1
165 FAILURE TO THRIVE 1
166 FEELING COLD 1
167 FLUID RETENTION 1
168 FLUORESCENT IN SITU HYBRIDISATION POSITIVE 1
169 GENITAL BURNING SENSATION 1
170 GENITAL DISCOMFORT 1
171 GLOMERULAR FILTRATION RATE ABNORMAL 1
172 HAEMORRHAGE URINARY TRACT 1
173 HEAD INJURY 1
174 HEPATOMEGALY 1
175 HYPERSENSITIVITY 1
176 HYPERSOMNIA 1
177 HYPOTENSION 1
178 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
179 INJURY ASSOCIATED WITH DEVICE 1
180 INSOMNIA 1
181 IRRITABLE BOWEL SYNDROME 1
182 ISCHAEMIC STROKE 1
183 JOINT SWELLING 1
184 KLEBSIELLA BACTERAEMIA 1
185 LABILE BLOOD PRESSURE 1
186 LACRIMATION INCREASED 1
187 LIP DRY 1
188 LIQUID PRODUCT PHYSICAL ISSUE 1
189 LIVER DISORDER 1
190 LOSS OF CONSCIOUSNESS 1
191 LOSS OF THERAPEUTIC RESPONSE 1
192 LYMPHADENOPATHY 1
193 LYMPHOMA 1
194 MASS 1
195 MEAN CELL HAEMOGLOBIN INCREASED 1
196 MEAN CELL VOLUME INCREASED 1
197 METASTASES TO BONE 1
198 METASTASES TO TRACHEA 1
199 METASTASIS 1
200 MICTURITION DISORDER 1
201 MOBILITY DECREASED 1
202 MUSCLE FATIGUE 1
203 MUSCULAR WEAKNESS 1
204 MUSCULOSKELETAL CHEST PAIN 1
205 MYOCARDIAL NECROSIS MARKER INCREASED 1
206 NASOPHARYNGITIS 1
207 NEOPLASM 1
208 NEUTROPHIL COUNT INCREASED 1
209 NOCTURIA 1
210 NORMOCHROMIC ANAEMIA 1
211 OPTIC NEURITIS 1
212 ORTHOSTATIC HYPOTENSION 1
213 PAIN IN EXTREMITY 1
214 PALPITATIONS 1
215 PERICARDITIS 1
216 PERSONALITY CHANGE 1
217 PHARYNGEAL HAEMORRHAGE 1
218 PNEUMATURIA 1
219 PNEUMONIA ADENOVIRAL 1
220 POLYARTHRITIS 1
221 POLYURIA 1
222 POST PROCEDURAL COMPLICATION 1
223 POST PROCEDURAL HAEMORRHAGE 1
224 PRESYNCOPE 1
225 PROCEDURAL PAIN 1
226 PRODUCT ADMINISTRATION ERROR 1
227 PRODUCT AVAILABILITY ISSUE 1
228 PRODUCT COMPLAINT 1
229 PRODUCT PREPARATION ERROR 1
230 PRODUCT STORAGE ERROR 1
231 PRURITUS 1
232 RECURRENT CANCER 1
233 RED BLOOD CELL COUNT DECREASED 1
234 RENAL IMPAIRMENT 1
235 RENAL PAIN 1
236 SCROTAL PAIN 1
237 SEIZURE 1
238 SEPTIC ENCEPHALOPATHY 1
239 SKIN ODOUR ABNORMAL 1
240 SPINAL CORD COMPRESSION 1
241 SPINAL CORD HAEMATOMA 1
242 SUDDEN DEATH 1
243 SYRINGE ISSUE 1
244 THERAPY CESSATION 1
245 THERAPY CHANGE 1
246 TONGUE PRURITUS 1
247 TRANSITIONAL CELL CARCINOMA RECURRENT 1
248 TREATMENT NONCOMPLIANCE 1
249 UNDERDOSE 1
250 UNEVALUABLE EVENT 1
251 UPPER LIMB FRACTURE 1
252 URETHRITIS NONINFECTIVE 1
253 URGE INCONTINENCE 1
254 URINARY SEDIMENT 1
255 URINARY TRACT DISORDER 1
256 URINARY TRACT INFECTION BACTERIAL 1
257 URINARY TRACT INFECTION ENTEROCOCCAL 1
258 URINE CYTOLOGY ABNORMAL 1
259 URINE FLOW DECREASED 1
260 UROSEPSIS 1
261 URTICARIA 1
262 VIRAEMIA 1
263 VISION BLURRED 1
264 VULVOVAGINAL BURNING SENSATION 1
265 VULVOVAGINAL DISCOMFORT 1